IRIS - Res&Arch Institutional Research Information System - Research & Archive

COSTA, CINZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.187
EU - Europa 1.902
AS - Asia 601
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.184
IE - Irlanda 506
IT - Italia 316
UA - Ucraina 304
HK - Hong Kong 292
SE - Svezia 211
FR - Francia 187
CN - Cina 132
VN - Vietnam 108
RU - Federazione Russa 84
FI - Finlandia 82
DE - Germania 79
GB - Regno Unito 48
SG - Singapore 40
RO - Romania 26
BE - Belgio 17
CH - Svizzera 12
TR - Turchia 10
NL - Olanda 9
LB - Libano 6
EU - Europa 5
GR - Grecia 5
UZ - Uzbekistan 5
AT - Austria 4
CL - Cile 3
CZ - Repubblica Ceca 3
MX - Messico 3
AR - Argentina 2
ES - Italia 2
JP - Giappone 2
MO - Macao, regione amministrativa speciale della Cina 2
PL - Polonia 2
RS - Serbia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
IL - Israele 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
Totale 4.702
Salva come PNG Salva come JPEG
Città #
Chandler 569
Dublin 501
Hong Kong 292
San Mateo 203
Jacksonville 170
Altamura 137
Medford 111
Dong Ket 108
Princeton 108
Perugia 107
Lawrence 101
Wilmington 86
Ann Arbor 82
Andover 74
Beijing 65
Des Moines 51
Redmond 43
Los Angeles 23
San Paolo di Civitate 21
Singapore 21
Saint Petersburg 19
Bucharest 18
Woodbridge 18
Norwalk 17
Brussels 15
Helsinki 15
Boardman 12
Izmir 10
Falls Church 9
Redwood City 9
Boydton 8
Moscow 8
Ashburn 6
Den Haag 6
London 6
Cava de' Tirreni 4
Falkenstein 4
Houston 4
Lappeenranta 4
Pomezia 4
Terni 4
Auburn Hills 3
Zhengzhou 3
Chicago 2
Hasselt 2
Jesi 2
Milan 2
Munich 2
Munro 2
Nagold 2
San Diego 2
Santiago 2
Tappahannock 2
Timisoara 2
Utrecht 2
Almaty 1
Altino 1
Amsterdam 1
Assisi 1
Bielefeld 1
Bologna 1
Cambridge 1
City Of Industry 1
Dearborn 1
Derio 1
Edinburgh 1
Ferrara 1
Florence 1
Frankfurt Am Main 1
Frankfurt am Main 1
Fremont 1
Grammichele 1
Guangzhou 1
Kalngale 1
Lausanne 1
Lebrija 1
Ludwigshafen 1
Ludwigshafen am Rhein 1
Maceió 1
Mogliano 1
Monterrey 1
Naples 1
Paris 1
Pars 1
Prague 1
Qingdao 1
Rome 1
Secaucus 1
Seoul 1
Southwell 1
Sovicille 1
Sydney 1
Tel Aviv 1
Tokyo 1
Woodford 1
Totale 3.143
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 141
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 86
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 82
Effect of psychotropic drugs on seizure threshold 81
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 79
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 79
Levetiracetam-associated hyponatremia. 75
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 75
Plasticity and repair in the post-ischemic brain 72
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 66
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 66
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 65
Hippocampal epileptogenesis in autoimmune encephalitis 63
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 62
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 61
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 61
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 61
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 59
Occipital arteriovenous malformations andmigraine. 58
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 58
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 57
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 56
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 55
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 54
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 54
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 52
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 51
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 51
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 50
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 50
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 50
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 49
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 48
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 48
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 48
Brain arteriovenous malformations and seizures: an Italian study. 48
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 46
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 45
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 45
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 45
Cortical spreading depression as a target for anti-migraine agents. 44
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 44
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 44
Management of epilepsy in brain tumors 44
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 43
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 43
Pathways of neurodegeneration and experimental models of basal ganglia disorders: downstream effects of mitochondrial inhibition. 43
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 42
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 41
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 41
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 41
Chronic cocaine prevents depotentiation at corticostriatal synapses. 40
Amyloid-β: a potential link between epilepsy and cognitive decline 40
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 39
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 39
null 39
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 39
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 39
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 38
Levetiracetam protects against kainic acid-induced toxicity. 38
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 38
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 38
Migraine and epilepsy: what value today? 38
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 37
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 37
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 36
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. 36
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 36
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 36
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 35
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 35
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 35
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 35
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 35
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 35
Identification of amoeba in the CSF in a patient with meningoencephalitis 34
Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina. 34
Modelli sperimentali 34
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 34
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 33
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 33
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 33
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 33
Obsessive-compulsive disorder and migraine with medication-overuse headache. 33
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 32
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 32
Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. 31
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 31
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 31
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 31
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 30
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 30
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 30
Cefalee e sonno 29
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 29
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 29
Striatum-hippocampusbalance: from physiological behavior to interneuronal pathology. 26
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. 25
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 25
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 24
Totale 4.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 13 3
2019/2020477 59 10 55 5 43 43 53 47 56 62 7 37
2020/2021774 7 45 27 49 226 37 65 29 86 25 59 119
2021/2022901 15 168 30 42 33 13 13 262 19 54 124 128
2022/20231.839 118 378 33 151 166 195 0 67 660 8 46 17
2023/2024611 43 75 34 10 3 3 177 11 117 26 112 0
Totale 4.954